Michael Vallone currently serves as the Senior Director of Commercialization at Ignite Proteomics since May 2024. Prior to this role, Michael held the same position at Theralink Technologies, Inc. from December 2022 to July 2024. Michael has a diverse background in the healthcare sector, including positions as a Contract Manager at Oxford Health Plans and United Health Care between 2003 and 2007. In the span of 2007 to 2014, Michael worked at Myriad Genetics, progressing through various roles including Oncology Product Consultant, Oncology Sales Manager, and Senior Manager. Michael earned a Bachelor of Science degree in Business Economics from Rutgers University from 1993 to 1997.
This person is not in the org chart
This person is not in any teams
This person is not in any offices